Sign up Australia
Proactive Investors - Run By Investors For Investors

Laguna Blends' cannabidiol serum trials show "100% improvement"

"Obviously when you receive a 100% improvement with a product you have a home run type of product with proven science and clinical data.”
Cannabis plants
Cannabidiol is a non-psychoactive extract found in the hemp plant.

Shares in Laguna Blends Inc (CSE:LAG) shot up after a clinical trial of its facial serum showed 100% overall improvement of the skin appearance in all subjects.

In a two week trial of the cannabis extract facial serum, all 21 of the female test subjects reported an overall improvement in the appearance of their skin, including skin texture and wrinkles.

"Obviously when you receive a 100% improvement with a product you have a home run type of product with proven science and clinical data,” said president Ray Grimm.

The group recently announced that it had entered into a non-binding letter of intent to acquire the exclusive license and Cannaceuticals “Canna” brand name of the Swiss developed cannabis extract skin care line.

“Management believes that this proposed acquisition will immediately establish Laguna as a player in the skin care category,” said Grimm.

Assuming it is able to acquire rights to these products under a definitive agreement, the group anticipates that this will position it to be a player within the direct sales industry.

According to a recent report, the global skin care industry is expected to reach US$121bn in 2016.

Laguna’s face serum uses cannabidiol, a non-psychoactive cannabinoid extract found in the hemp plant. It and all other cannabinoids in the cannabis plant were patented by the United States Government in 2003 as neuroprotectants and antioxidants.

Shares rose 12.5% to US$0.27.

View full LAG profile View Profile

Laguna Blends Timeline

Related Articles

April 17 2018
The group's major shareholders have staunchly supported the business while the AIM-listed group sorts out its financial position

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use